Dirk Woitalla Selected Research

entacapone (Comtan)

10/2022	[Relevance of COMT inhibitors in the treatment of motor fluctuations].
7/2008	Entacapone improves absorption of a coadministered salt in patients with Parkinson's disease.
5/2007	Entacapone improves complex movement performance in patients with Parkinson's disease.
3/2006	Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients.
3/2006	Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Woitalla Research Topics

Disease

31	Parkinson Disease (Parkinson's Disease) 10/2022 - 06/2002
3	Neurosarcoidosis 01/2018 - 11/2010
2	Pain (Aches) 01/2019 - 01/2011
1	Diarrhea 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2018
1	Disease Progression 05/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2014
1	Parkinsonian Disorders (Parkinsonism) 01/2013
1	Viral Meningitis 11/2010
1	Bacterial Meningitis 11/2010
1	Encephalitis (Encephalitis, Rasmussen) 11/2010
1	Central Nervous System Vasculitis 11/2010
1	Parkinson Disease 11 01/2008
1	Anosmia 01/2008
1	Dyskinesias (Dyskinesia) 01/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2006
1	Alzheimer Disease (Alzheimer's Disease) 05/2002
1	Huntington Disease (Huntington's Disease) 05/2002

Drug/Important Bio-Agent (IBA)

11	Levodopa (L Dopa)FDA LinkGeneric 06/2018 - 06/2004
6	Proteins (Proteins, Gene)FDA Link 03/2016 - 05/2002
5	entacapone (Comtan)FDA Link 10/2022 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2008
4	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 06/2011 - 03/2006
2	rotigotine FDA Link 06/2018 - 03/2015
2	CytokinesIBA 10/2014 - 06/2002
2	AntibodiesIBA 01/2014 - 01/2008
2	mortalinIBA 01/2013 - 11/2010
2	alpha-SynucleinIBA 01/2008 - 09/2005
2	Carbidopa (Lodosyn)FDA LinkGeneric 05/2007 - 03/2006
1	Tolcapone (Tasmar)FDA Link 10/2022
1	opicaponeIBA 10/2022
1	catechol (pyrocatechol)IBA 10/2022
1	Monoamine Oxidase (MAO)IBA 09/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Protein Deglycase DJ-1IBA 01/2020
1	AcidsIBA 01/2020
1	IronIBA 01/2019
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2018
1	Serine Proteases (Serine Protease)IBA 03/2016
1	PTEN-induced putative kinaseIBA 03/2016
1	PresenilinsIBA 03/2016
1	Immunoglobulin G (IgG)IBA 01/2014
1	Biological ProductsIBA 01/2013
1	HomocysteineIBA 06/2011
1	Dopa DecarboxylaseIBA 06/2011
1	Asu(1,6)- argipressin (VAS-A)IBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2011
1	ImmunosorbentsIBA 11/2010
1	EnzymesIBA 11/2010
1	temiverineIBA 11/2010
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 11/2010
1	Indicators and Reagents (Reagents)IBA 11/2010
1	Amantadine (Aman)FDA LinkGeneric 09/2010
1	Adenosine Triphosphatases (ATPase)IBA 08/2008
1	SaltsIBA 07/2008
1	neuromelaninIBA 01/2008
1	Apomorphine FDA Link 01/2008
1	Growth Hormone (Somatotropin)IBA 07/2007
1	Fluvoxamine (Luvox)FDA LinkGeneric 10/2006
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 10/2006
1	CytochromesIBA 10/2006
1	Antidepressive Agents (Antidepressants)IBA 10/2006
1	TabletsIBA 03/2006
1	octanoic acid (caprylic acid)IBA 03/2005
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 06/2002
1	GelsIBA 05/2002

Therapy/Procedure

4	Therapeutics 09/2020 - 03/2015
2	Drug Therapy (Chemotherapy) 09/2020 - 01/2011
1	Transdermal Patch 03/2015